SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dov Pharmaceutical, Inc - DOVP -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (132)4/25/2006 3:13:24 AM
From: Robohogs  Respond to of 172
 
Has anyone done a valuation on indi royalty alone? I must admit to this news destroying my already-poorly performing charity portfolio but no skin off my real back, than goodness. Two hits on low to medium size holdings and one poorly performing core holding are enough for me for now.

Jon



To: nigel bates who wrote (132)4/25/2006 3:13:24 AM
From: Robohogs  Read Replies (2) | Respond to of 172
 
Has anyone done a valuation on indi royalty alone? I must admit to this news destroying my already-poorly performing charity portfolio but no skin off my real back, than goodness. Two hits on low to medium size holdings and one poorly performing core holding are enough for me for now.

Jon



To: nigel bates who wrote (132)4/25/2006 2:59:05 PM
From: keokalani'nui  Read Replies (1) | Respond to of 172
 
>>avoided a train wreck for once<<

Me too

:--)

But it was in your contest entry?!? Now that's a disaster.

:--(


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News